Yubin Zhou, MD, Ph.D.

In a remarkable breakthrough that could reshape cellular immunotherapy and broaden our understanding of calcium signaling, researchers at Texas A&M Health have engineered genetically encoded peptide inhibitors to precisely modulate a critical calcium entry pathway in cells. Their pioneering work targets the store-operated calcium entry (SOCE) mechanism, a central conduit through which calcium ions enter cells, modulating vital physiological functions including immune responses, muscle contraction, and neuronal activity.

Calcium’s role transcends its well-known function in bone health; it acts as an indispensable intracellular messenger, carrying signals that dictate cellular behavior and fate. The SOCE pathway is triggered when the endoplasmic reticulum (ER), the cell’s principal calcium reservoir, detects depleted internal calcium stores… Continue reading.

In a significant breakthrough in cancer research, scientists from the Texas A&M University Health Science Center (Texas A&M Health) have uncovered a previously unknown mechanism that fuels the growth of a rare and aggressive form of kidney cancer, known as translocation renal cell carcinoma (tRCC). This discovery, detailed in a recent study published in Nature Communications, highlights how tiny molecular “hubs” within cancer cells utilize RNA in a manner that accelerates disease progression, presenting new avenues for potential treatments.

Translocation renal cell carcinoma, primarily affecting children and young adults, currently lacks effective therapeutic options, making this research particularly crucial. The cancer arises from abnormal hybrid genes called TFE3 oncofusions, which occur due to chromosomal errors. Until now, the precisely aggressive nature of tRCC and the role of these fusion proteins had eluded researchers… Continue reading.